Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9543753rdf:typepubmed:Citationlld:pubmed
pubmed-article:9543753lifeskim:mentionsumls-concept:C0042776lld:lifeskim
pubmed-article:9543753lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:9543753lifeskim:mentionsumls-concept:C0005795lld:lifeskim
pubmed-article:9543753lifeskim:mentionsumls-concept:C0013331lld:lifeskim
pubmed-article:9543753pubmed:issue32lld:pubmed
pubmed-article:9543753pubmed:dateCreated1998-6-9lld:pubmed
pubmed-article:9543753pubmed:abstractTextInfection with human T-lymphotrophic virus (HTLV) type 1 causes a neurological disorder or leukaemia in a minority of infected persons. Since January 1993 the Dutch blood banks screen each donation for presence of HTLV-1 infection. Approximately 4,000,000 donations from 700,000 donors have been tested. The numbers of confirmed HTLV-1 positive donors were: 1993: 15; 1994: 6; 1995: 8; 1996: 3. In 1995 one case of HTLV-2 infection was detected as well. In 26/32 (81%) of the HTLV-1 positive cases either the donor or his/her partner originated from HTLV-1 endemic areas. The introduction of HTLV screening prevents the silent spread of HTLV via blood transfusion.lld:pubmed
pubmed-article:9543753pubmed:languagedutlld:pubmed
pubmed-article:9543753pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9543753pubmed:citationSubsetIMlld:pubmed
pubmed-article:9543753pubmed:statusMEDLINElld:pubmed
pubmed-article:9543753pubmed:monthAuglld:pubmed
pubmed-article:9543753pubmed:issn0028-2162lld:pubmed
pubmed-article:9543753pubmed:authorpubmed-author:LelieP NPNlld:pubmed
pubmed-article:9543753pubmed:authorpubmed-author:van der...lld:pubmed
pubmed-article:9543753pubmed:authorpubmed-author:ZaaijerH LHLlld:pubmed
pubmed-article:9543753pubmed:issnTypePrintlld:pubmed
pubmed-article:9543753pubmed:day9lld:pubmed
pubmed-article:9543753pubmed:volume141lld:pubmed
pubmed-article:9543753pubmed:ownerNLMlld:pubmed
pubmed-article:9543753pubmed:authorsCompleteYlld:pubmed
pubmed-article:9543753pubmed:pagination1571-2lld:pubmed
pubmed-article:9543753pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9543753pubmed:meshHeadingpubmed-meshheading:9543753-...lld:pubmed
pubmed-article:9543753pubmed:meshHeadingpubmed-meshheading:9543753-...lld:pubmed
pubmed-article:9543753pubmed:meshHeadingpubmed-meshheading:9543753-...lld:pubmed
pubmed-article:9543753pubmed:meshHeadingpubmed-meshheading:9543753-...lld:pubmed
pubmed-article:9543753pubmed:meshHeadingpubmed-meshheading:9543753-...lld:pubmed
pubmed-article:9543753pubmed:year1997lld:pubmed
pubmed-article:9543753pubmed:articleTitle[Infection with T-lymphotropic virus in Dutch blood donors, 1993-1996].lld:pubmed
pubmed-article:9543753pubmed:affiliationAcademisch Ziekenhuis Vrije Universiteit, afd. Klinische Microbiologie en Ziekenhuishygiënè, Amsterdam.lld:pubmed
pubmed-article:9543753pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9543753pubmed:publicationTypeEnglish Abstractlld:pubmed